CD40-LIGAND-FUSIONSPROTEINIMPFSTOFF

European patent · EP1951862 · Deleted

Register entry

Publication number: EP1951862
Application number: EP06827550
Kind: European patent with effect for Switzerland and Liechtenstein
Status: Deleted
Specification: Granted
Filed: Nov 6, 2006
Published: Aug 6, 2008
Granted: Jul 24, 2013
Deleted: Nov 30, 2013
Reason: Annual fee unpaid
IPC classes: C12N 5/00 (2006.01)
C07K 1/00 (2006.01)
Priority: US 734136 P 07.11.2005
US 755885 P 04.01.2006
US 789270 P 04.04.2006
US 793206 P 19.04.2006
US 853184 P 20.10.2006
PCT application: PCT/US2006/043164 06.11.2006
PCT publication: WO2007/056266 18.05.2007
Filing language: English
Source: Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

Jun 18, 2014
Deleted, fee unpaid
Published in Swissreg on 18.06.2014
Jul 24, 2013
Granted
Published in Swissreg on 24.07.2013

Parties

Holder

MicroVAX, LLC

Mason Enterprise Center 10900 University Blvd., Ms 1 J2, Manassas, VA 20110, US

Inventor

TANG, Yucheng

San Diego, CA 92121, US

DEISSEROTH, Albert

San Diego, CA 92172, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.